Actinogen Medical Ltd (ACW) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.507x

Based on the latest financial reports, Actinogen Medical Ltd (ACW) has a cash flow conversion efficiency ratio of -0.507x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.29 Million ≈ $-6.58 Million USD) by net assets (AU$18.34 Million ≈ $12.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Actinogen Medical Ltd for the company's overall valuation and market capitalisation.

Actinogen Medical Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Actinogen Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Actinogen Medical Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Actinogen Medical Ltd ranked by their cash flow conversion efficiency. See debt repayment capacity of Actinogen Medical Ltd to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Gurit Holding AG SW:GURN	0.570x
Biosyent Inc. V:RX	0.069x
Alicon Castalloy Limited NSE:ALICON	0.185x
SKM Egg Products Export (India) Limited NSE:SKMEGGPROD	-0.028x
Bank Mnc Internasional Tbk JK:BABP	-0.183x
Action Electronics Co Ltd TW:3024	-0.039x
Harbour Link Group Bhd KLSE:2062	0.023x
Waldencast Acquisition Corp NASDAQ:WALD	-0.003x

Annual Cash Flow Conversion Efficiency for Actinogen Medical Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Actinogen Medical Ltd from 2008 to 2025. View current stock price of Actinogen Medical Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$18.34 Million ≈ $12.97 Million	AU$-7.56 Million ≈ $-5.35 Million	-0.412x	+52.12%
2024-06-30	AU$19.70 Million ≈ $13.94 Million	AU$-16.95 Million ≈ $-11.99 Million	-0.861x	-32.65%
2023-06-30	AU$13.41 Million ≈ $9.49 Million	AU$-8.70 Million ≈ $-6.15 Million	-0.649x	-48.20%
2022-06-30	AU$21.74 Million ≈ $15.38 Million	AU$-9.52 Million ≈ $-6.73 Million	-0.438x	-343.34%
2021-06-30	AU$17.46 Million ≈ $12.35 Million	AU$-1.72 Million ≈ $-1.22 Million	-0.099x	+62.35%
2020-06-30	AU$10.89 Million ≈ $7.70 Million	AU$-2.86 Million ≈ $-2.02 Million	-0.262x	+60.87%
2019-06-30	AU$15.66 Million ≈ $11.08 Million	AU$-10.50 Million ≈ $-7.43 Million	-0.670x	-46.20%
2018-06-30	AU$17.26 Million ≈ $12.21 Million	AU$-7.91 Million ≈ $-5.60 Million	-0.458x	-287.20%
2017-06-30	AU$9.37 Million ≈ $6.63 Million	AU$-1.11 Million ≈ $-784.55K	-0.118x	+71.51%
2016-06-30	AU$12.13 Million ≈ $8.58 Million	AU$-5.04 Million ≈ $-3.57 Million	-0.416x	-71.57%
2015-06-30	AU$15.36 Million ≈ $10.87 Million	AU$-3.72 Million ≈ $-2.63 Million	-0.242x	+32.96%
2014-06-30	AU$1.21 Million ≈ $857.43K	AU$-437.84K ≈ $-309.80K	-0.361x	+44.08%
2013-06-30	AU$194.35K ≈ $137.52K	AU$-125.56K ≈ $-88.85K	-0.646x	+72.79%
2012-06-30	AU$346.99K ≈ $245.52K	AU$-823.94K ≈ $-582.99K	-2.375x	-208.31%
2011-06-30	AU$1.05 Million ≈ $740.20K	AU$-805.70K ≈ $-570.09K	-0.770x	-23.70%
2010-06-30	AU$1.17 Million ≈ $826.62K	AU$-727.37K ≈ $-514.66K	-0.623x	-116.57%
2009-06-30	AU$1.90 Million ≈ $1.35 Million	AU$-546.87K ≈ $-386.95K	-0.287x	-106.93%
2008-06-30	AU$2.86 Million ≈ $2.02 Million	AU$-397.22K ≈ $-281.06K	-0.139x	--

About Actinogen Medical Ltd

AU:ACW Australia Biotechnology

Market Cap

$130.44 Million

AU$184.35 Million AUD

Market Cap Rank

#18273 Global

#557 in Australia

Share Price

AU$0.06

Change (1 day)

-7.94%

52-Week Range

AU$0.03 - AU$0.07

All Time High

AU$0.18